|
|
Obsidian Therapeutics Inc
NASDAQ •
Healthcare •
Biotechnology •
Quote as of 10/07/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization816.64 mln
Float54.11 mln
1-Year Forecast
39.00
Transformational upside
Relative Strength
11
/ 100
Significantly lagging
Key Fundamentals
EPS-1.63
ROIC-1,188
ROA819
EBITDA, mln125
EV / EBITDA9.15
EV / EBIT9.20
Quote Details
Last
13.20
Change
-0.02 (-0.15%)
Open
13.02
Volume
359,041
Turnover
4,739,341
Average Volume
705,401
Financial Ratios
Current Ratio2.30
Debt / Equity0.10
Financial Strength
1-Year Target Price39.00
Short Ratio0.92
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-3.86% |
20
/ 100
 |
| 1 Month |
-29.52% |
7
/ 100
 |
|
| |
